Clinical Trials in Mudanjiang, Heilongjiang
6 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled69 locationsNCT07047365
Recruiting
Phase 3
Normobaric Oxygen in AIS Transferred for EVT
Ischemic Stroke
Capital Medical University1,500 enrolled112 locationsNCT06666764
Recruiting
Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Cardiac dysfunctionCoronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Not Applicable
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
Percutaneous Coronary InterventionST-segment elevation myocardial infarction (STEMI)Cardioprotection
Harbin Medical University250 enrolled9 locationsNCT04912518
Recruiting
Not Applicable
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Acute Coronary Syndrome (ACS)
Harbin Medical University1,860 enrolled18 locationsNCT06365502